PFS
COLL icon

Prospera Financial Services’s Collegium Pharmaceutical COLL Stock Holding History

Prospera Financial Services’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,536
Closed -$194K – 1790
2022
Q1 		$194K Buy
+9,536
New +$180K 0.01% 892
2020
Q4 		– Sell
-10,004
Closed -$208K – 838
2020
Q3 		$208K Buy
+10,004
New +$181K 0.08% 225
2020
Q1 		– Sell
-13,751
Closed -$283K – 527
2019
Q4 		$283K Buy
+13,751
New +$229K 0.02% 493

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Prospera Financial Services's COLL Position: Q2 2022 in Review

Prospera Financial Services sold out of Collegium Pharmaceutical (COLL) in Q2 2022, closing a stake of 9,536 shares — an estimated $194K sold.

Prospera Financial Services first reported a position in COLL in Q4 2019 and held it in 3 quarters. The position peaked at $283K in Q4 2019. 157 funds tracked by Wall St. Rank hold COLL as of Q2 2022.

  • Prospera Financial Services reported no remaining Collegium Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Prospera Financial Services sold 9,536 Collegium Pharmaceutical shares in Q2 2022, an estimated $194K.
  • Prospera Financial Services first reported a position in Collegium Pharmaceutical in Q4 2019 and held it in 3 quarters.
  • Prospera Financial Services's Collegium Pharmaceutical position peaked at $283K in Q4 2019.
  • 157 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.